[go: up one dir, main page]

NO20080993L - Fremgangsmate for a forbedre arvakenhet - Google Patents

Fremgangsmate for a forbedre arvakenhet

Info

Publication number
NO20080993L
NO20080993L NO20080993A NO20080993A NO20080993L NO 20080993 L NO20080993 L NO 20080993L NO 20080993 A NO20080993 A NO 20080993A NO 20080993 A NO20080993 A NO 20080993A NO 20080993 L NO20080993 L NO 20080993L
Authority
NO
Norway
Prior art keywords
inheritance
improving
procedure
imidazolylalkyl
pyridines
Prior art date
Application number
NO20080993A
Other languages
English (en)
Inventor
Christian N Lavedan
Mihael H Polymeropoulos
Original Assignee
Vanda Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanda Pharmaceuticals Inc filed Critical Vanda Pharmaceuticals Inc
Publication of NO20080993L publication Critical patent/NO20080993L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)

Abstract

Foreliggende oppfinnelse relaterer til anvendelse av visse imidazolylalkyl-pyridiner for å forbedre årvåkenhet.
NO20080993A 2005-07-29 2008-02-25 Fremgangsmate for a forbedre arvakenhet NO20080993L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70360405P 2005-07-29 2005-07-29
US73253605P 2005-11-02 2005-11-02
PCT/US2006/029112 WO2007016203A1 (en) 2005-07-29 2006-07-26 Method of improving wakefulness

Publications (1)

Publication Number Publication Date
NO20080993L true NO20080993L (no) 2008-02-25

Family

ID=37708941

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080993A NO20080993L (no) 2005-07-29 2008-02-25 Fremgangsmate for a forbedre arvakenhet

Country Status (11)

Country Link
US (1) US20080280954A1 (no)
EP (1) EP1919477B1 (no)
JP (1) JP5017268B2 (no)
KR (2) KR101187461B1 (no)
AU (1) AU2006275824B2 (no)
BR (1) BRPI0614701A2 (no)
CA (1) CA2616177C (no)
ES (1) ES2388876T3 (no)
NO (1) NO20080993L (no)
NZ (1) NZ565763A (no)
WO (1) WO2007016203A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101394849A (zh) 2006-02-13 2009-03-25 Vanda制药公司 咪唑基烷基-吡啶的稳定的剂量制剂
JP2009538332A (ja) * 2006-05-22 2009-11-05 ヴァンダ ファーマシューティカルズ インコーポレイテッド メラトニンアゴニスト治療
WO2009097414A1 (en) * 2008-01-29 2009-08-06 Vanda Pharmaceuticals, Inc. Use of imidazolylalkyl-pyridines for the treatment of addictive disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
RU2631602C2 (ru) 2012-01-26 2017-09-25 Ванда Фармасьютиклз Инк. Лечение нарушений циркадного ритма
EP2861244B1 (en) * 2012-06-14 2018-09-19 The Regents Of The University Of Michigan Sleep apnea treatment
KR20170058464A (ko) 2012-12-18 2017-05-26 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
CN103087019B (zh) * 2013-02-06 2015-02-04 济南志合医药科技有限公司 一种他司美琼的制备方法
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
DE4131584A1 (de) * 1991-09-23 1993-03-25 Sandoz Ag Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
EP0885210B2 (en) 1996-03-08 2008-06-18 Takeda Pharmaceutical Company Limited Tricylic compounds having binding affinity for melatonin receptors, their production and use
US20010034373A1 (en) 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
GB0009037D0 (en) * 2000-04-13 2000-05-31 Novartis Ag Organic compounds
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia

Also Published As

Publication number Publication date
HK1117402A1 (en) 2009-01-16
KR101187461B1 (ko) 2012-10-02
KR20110011748A (ko) 2011-02-08
NZ565763A (en) 2010-12-24
CA2616177C (en) 2012-05-01
US20080280954A1 (en) 2008-11-13
AU2006275824A1 (en) 2007-02-08
AU2006275824B2 (en) 2010-12-16
EP1919477B1 (en) 2012-07-11
KR20080033322A (ko) 2008-04-16
CA2616177A1 (en) 2007-02-08
ES2388876T3 (es) 2012-10-19
BRPI0614701A2 (pt) 2011-04-12
EP1919477A4 (en) 2009-03-18
WO2007016203A1 (en) 2007-02-08
KR101146807B1 (ko) 2012-05-21
EP1919477A1 (en) 2008-05-14
JP2009502945A (ja) 2009-01-29
JP5017268B2 (ja) 2012-09-05

Similar Documents

Publication Publication Date Title
NO20080993L (no) Fremgangsmate for a forbedre arvakenhet
WO2011133875A3 (en) Metalloenzyme inhibitor compounds
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
EA201170521A1 (ru) Новые соединения
PH12013502623A1 (en) Metalloenzyme inhibitor compounds
PH12013502624A1 (en) Metalloenzyme inhibitor compounds
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
EA201270049A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
WO2011082245A3 (en) Metalloenzyme inhibitor compounds
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
MX2009009491A (es) Compuestos y composiciones como moduladores de la actividad del gpr119.
MY164646A (en) Nicotine lozenge compositions
IN2012DN03883A (no)
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
TW200745109A (en) Pyrrolo-pyridine kinase modulators
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
WO2012064943A3 (en) Metalloenzyme inhibitor compounds
WO2007115821A3 (en) Organic compounds
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
MX2009013353A (es) Compuestos activadores de telomerasa y metodos para su uso.
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
MY159491A (en) Disubstituted phthalazine hedgehog pathway antagonists
NO20082298L (no) Kaliumkanalinhibitorer
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application